Literature DB >> 7793075

HIV-1 infection of primary human neuroblasts.

F Ensoli1, A Cafaro, V Fiorelli, B Vannelli, B Ensoli, C J Thiele.   

Abstract

Central nervous system (CNS) disorders are frequent in HIV-1-infected individuals, particularly in newborns and children, and are accompanied by histological alterations resulting in neuronal loss. Although several tumor-derived neuroectodermal cell lines can be infected by HIV-1, it has been reported that primary neural cells cannot be infected after they differentiate. However, pediatric AIDS is often the result of HIV-1 infection occurring during fetal development and early postnatal life, when neural cells are not yet differentiated. Here we show that primary cell cultures derived from the human fetal olfactory system which are representative of the developing CNS can be infected by both HIV-1 strains, the monocyte-macrophagotropic BaL and the lymphotropic HTLV-IIIB, although they do not express the CD4 molecule. In addition, the levels of viral replication are higher with the HIV-1 BaL than with the IIIB isolate. These results suggest that (1) during development immature neurons are susceptible to HIV-1 infection; (2) monocyte-macrophagotropic HIV-1 strains may preferentially be involved in the productive infection of the nervous system; and (3) a mechanism(s) other than the CD4-mediated viral entry is responsible for HIV-1 infection of immature neurons.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7793075     DOI: 10.1006/viro.1995.1336

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  15 in total

1.  A mechanism of restricted human immunodeficiency virus type 1 expression in human glial cells.

Authors:  M Shahabuddin; G Bentsman; B Volsky; I Rodriguez; D J Volsky
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

2.  Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo.

Authors:  P Bagnarelli; A Valenza; S Menzo; R Sampaolesi; P E Varaldo; L Butini; M Montroni; C F Perno; S Aquaro; D Mathez; J Leibowitch; C Balotta; M Clementi
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

Review 3.  Vertical human immunodeficiency virus-1 infection: involvement of the central nervous system and treatment.

Authors:  C Exhenry; D Nadal
Journal:  Eur J Pediatr       Date:  1996-10       Impact factor: 3.183

4.  HIV-1 infection of neurons might account for progressive HIV-1-associated encephalopathy in children.

Authors:  Carmen Cantó-Nogués; Silvia Sánchez-Ramón; Susana Alvarez; César Lacruz; Ma Angeles Muñóz-Fernández
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

Review 5.  Involvement of quinolinic acid in AIDS dementia complex.

Authors:  Gilles J Guillemin; Stephen J Kerr; Bruce J Brew
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

6.  Neuronal toxicity in HIV CNS disease.

Authors:  Jane Kovalevich; Dianne Langford
Journal:  Future Virol       Date:  2012-07-01       Impact factor: 1.831

7.  Contribution of CNS cells in NeuroAIDS.

Authors:  Ashish Swarup Verma; Udai Pratap Singh; Premendra Dhar Dwivedi; Anchal Singh
Journal:  J Pharm Bioallied Sci       Date:  2010-10

8.  Human immunodeficiency virus type 1 infection of human brain-derived progenitor cells.

Authors:  Diane M P Lawrence; Linda C Durham; Lynnae Schwartz; Pankaj Seth; Dragan Maric; Eugene O Major
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

Review 9.  Human immunodeficiency virus infection of the brain: pitfalls in evaluating infected/affected cell populations.

Authors:  Stephanie J Bissel; Clayton A Wiley
Journal:  Brain Pathol       Date:  2004-01       Impact factor: 6.508

10.  M- and T-tropic HIVs promote apoptosis in rat neurons.

Authors:  Alessia Bachis; Francesca Biggio; Eugene O Major; Italo Mocchetti
Journal:  J Neuroimmune Pharmacol       Date:  2008-11-26       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.